Indian Health Minister emphasizes on coordination for medical countermeasures
Indian Union Health Minister Dr. Mansukh Mandaviya emphasized on the importance of a formal global coordination mechanism for medical countermeasures and underscored the importance...
AstraZeneca starts Phase 2b clinical study of medicine to lower cholesterol: Ionis
Ionis Pharmaceuticals, Inc. has said that the AstraZeneca has commenced a Phase 2b clinical trial of ION449 (AZD8233).
It is an investigational antisense medicine designed...
OncoSec announces first subjects dosed in Phase 1 trial of COVID-19 vaccine candidate
OncoSec Medical Inc has announced that it has dosed several subjects in its Phase 1 clinical trial of CORVax12.
According to the company, it is...
Covid breakthrough: Baricitinib plus remdesivir show promising results in treating Corona infection
Covid treatment is no more a dream. In a relif to those who are waiting for Covid-19 medicine, it has emerged that combination of...
Sputnik V vaccine’s efficacy confirmed at 91.4%
Sputnik V, the Russian Covid-19 vaccine, has passed a crucial test. Its efficacy has been confirmed at 91.4 per cent bsed on data analysis...
Aster Labs unveils Digital Pathology Solution approved by USFDA
Aster Labs has introduced US FDA approved digital pathology solution at two of its facilities.
The diagnostics arm of Aster DM Healthcare, a healthcare service...
Research on preventative nasal spray reveals interesting results
Research on a 'novel' nasal spray therapy, INNA-051, which has been shown to reduce Covid-19 viral replication by up to 96 percent in a...
Biocon Biologics gets $150 mn capital dose from Goldman Sachs
The Board of Biocon Biologics Ltd has approved a Rs 1,125 Crore (~USD 150 million) capital injection from Goldman Sachs.
Biocon Biologics is a subsidiary...
Godrej partners with India’s universal immunisation programme
Godrej Appliances will be commissioning vaccine refrigerators and deep freezers under the pan India programme by Ministry of Health & Family Welfare.
It has commissioned...
Matrix Medical Network ties up with AstraZeneca
Matrix Medical Network has announced a partnership with AstraZeneca to accelerate a clinical trial in the US for AZD7442, AstraZeneca's long-acting monoclonal antibody (LAAB)...
